Lakefront Biotherapeutics NV
LKFTNASDAQHealthcareBiotechnology
As of Oct 22, 2026 close
- Market cap
- $2.07B
- P/E (TTM)
- 3.10
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $25.68$36.24
- Volume (live)
- -
- Avg. volume (3M)
- 328.78K
Lakefront Biotherapeutics NV (LKFT) Stock Price & Financial Analysis
Lakefront Biotherapeutics NV Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $30.55 - $31.53 |
|---|---|
| 52-Week High | $36.24 |
| 52-Week Low | $25.68 |
| Open | $30.62 |
| Volume (last close) | 307.94K |
| Average Volume (3M) | 328.78K |
| Revenue (TTM) | 1.11B |
|---|---|
| Net Income (TTM) | 668.90M |
| Free Cash Flow (TTM) | -259.56M |
| EPS (TTM) | $10.11 |
| Profit Margin | 60.23% |
| Operating Margin | 61.57% |
| Return on Equity (ROE) | 18.28% |
| Debt to Equity | 0.00 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 2.07B |
|---|---|
| Shares Outstanding | 66.04M |
| P/E Ratio (TTM) | 3.10 |
| Price to Sales (P/S) | 1.87 |
| Price to Book (P/B) | 0.57 |
| EV/EBITDA | 2.62 |
| 50-Day MA | $28.92 |
|---|---|
| 200-Day MA | $29.98 |
| 1-Year Change | −1.97% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
Lakefront Biotherapeutics NV at a Glance
As of the Oct 22, 2026 close, Lakefront Biotherapeutics NV (LKFT) has a market capitalization of $2.07B. The stock trades at 3.1× trailing earnings and 1.9× sales. Over the trailing twelve months it earned $668.90M on revenue of $1.11B (a 60.2% profit margin) and burned $259.56M of free cash flow. Revenue grew 259.4% year over year.
As of its latest reported balance sheet, it holds $152.42M in cash and securities against $7.13M of debt, a net cash position of $145.29M.
Lakefront Biotherapeutics NV does not currently pay a dividend.
The share price is down 2.0% over the past year. At $31.40 (the Oct 22, 2026 close) it sits within its 52-week range of $25.68 to $36.24, above its 200-day moving average of $29.98.
Frequently Asked Questions About Lakefront Biotherapeutics NV
What is the current stock price for LKFT?
As of the Oct 22, 2026 close, LKFT stock trades at $31.40. The 52-week range is $25.68–$36.24, with a day range of $30.55–$31.53.
What is the P/E ratio for LKFT?
As of the Oct 22, 2026 close, Lakefront Biotherapeutics NV's trailing twelve-month (TTM) P/E ratio is 3.1, meaning investors pay $3.1 for every $1 of annual earnings. Lakefront Biotherapeutics NV operates in the Healthcare sector.
Does LKFT pay dividends?
Lakefront Biotherapeutics NV does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for LKFT?
Analyst ratings and recommendations for LKFT are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of LKFT?
As of the Oct 22, 2026 close, Lakefront Biotherapeutics NV's market capitalization is $2.07B, classifying it as a mid-cap company. Lakefront Biotherapeutics NV operates in the Healthcare sector within the Biotechnology industry.